On July 11, 2025, Cantor Fitzgerald, under the analysis of Steve Seedhouse, announced the initiation of coverage on Innoviva (INVA, Financial). The firm assigned an "Overweight" rating to the stock, indicating a positive outlook.
Cantor Fitzgerald set a price target of $26.00 USD for Innoviva, highlighting the firm's expectation for the stock to outperform its peers in the market. This marks the first time the analyst has issued a rating or price target for INVA.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Innoviva Inc (INVA, Financial) is $55.00 with a high estimate of $55.00 and a low estimate of $55.00. The average target implies an upside of 188.56% from the current price of $19.06. More detailed estimate data can be found on the Innoviva Inc (INVA) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Innoviva Inc's (INVA, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Innoviva Inc (INVA, Financial) in one year is $23.57, suggesting a upside of 23.66% from the current price of $19.06. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Innoviva Inc (INVA) Summary page.
